NCT05317663

Brief Summary

Waterpipe (WP) smoking has become one of the leading tobacco use methods among youth in Florida. The impact of this dramatic rise is amplified by the mounting evidence of WP addictive and harmful nature, as well as the lag of policy response to it. Evidence suggests WP use leads to nicotine addiction, and increases the risk of lung cancer, heart and respiratory disease and exposure to secondhand smoke. The spread of WP use among youth has been fueled by a misperception of reduced-harm compared to cigarettes. Health Warning Labels (HWLs) represent one of the most successful tobacco control strategies to communicate smoking- related risks, and studies have consistently shown that HWLs are associated with a decrease in smoking rates and smoking-related morbidity and mortality. Therefore, communicating WP risks to young people through HWLs has been identified as a priority by major health bodies in the US including the FDA. Using the Delphi method among international tobacco control experts, our team has developed a set of 12 WP HWLs corresponding to 4 health themes; health risks/addiction, harm to others, WP-specific harm, WP harm compared to cigarettes. Building on this work, and using a mixed- method approach incorporating qualitative and quantitative research, the investigators propose to: Aim 1: Adapt the 12 HWLs to young WP smokers in Florida using exploratory focus groups. Aim 2: Test in a clinical lab experiment the performance of the top 4 HWLs on the WP device compared to no-HWL/control on harm perception, intention to quit, and toxicant exposure (Carbon monoxide (CO), nicotine, oxidative stress). Aim 3: Use the knowledge obtained to advocate for the adoption of WP-HWLs policies and disseminate information about WP harmful effects to young people in Florida and nationally. Communicating WP risks through HWLs promises to reduce WP use and WP-related morbidly and mortality among young adults in Florida. This pioneering work will inform the FDA and public health advocates on the potential of WP-HWLs policies and provide a model for other states to respond to the WP epidemic.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
44

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Oct 2022

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 28, 2022

Completed
1 month until next milestone

First Posted

Study publicly available on registry

April 8, 2022

Completed
6 months until next milestone

Study Start

First participant enrolled

October 3, 2022

Completed
2.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 9, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 9, 2024

Completed
Last Updated

December 10, 2024

Status Verified

December 1, 2024

Enrollment Period

2.2 years

First QC Date

February 28, 2022

Last Update Submit

December 9, 2024

Conditions

Keywords

waterpipeHealth warning labelYoung people

Outcome Measures

Primary Outcomes (1)

  • Intention and motivation to quit

    Intention and motivation to quit will be measured by using 3 items; "Does the participant intend to reduce WP smoking?"; "Does the participant intend to quit WP smoking?", and "How motivated is the participant to quit WP smoking in the next month?" The scale will be scored on a 5-point scale ranging from 1 (not at all), to 5 (very much).

    pre-/post-smoking and at 3-month assessment. Each session is approximately 45 minutes ad lib use period.

Secondary Outcomes (13)

  • Harm perception

    pre-/post-smoking and at 3-month assessment. Each session is approximately 45 minutes ad lib use period.

  • Exhaled Breath Condensate (EBC)

    It will be collected pre-post smoking session. Each session is approximately 45 minutes ad lib use period.

  • Social interaction

    at 3-month assessment

  • Change in WP smoking

    at 3-month assessment

  • Toxicant exposure: expired carbon monoxide

    initially at the beginning of the smoking session (abstinence verification), and within 10 minutes after the WP smoking session

  • +8 more secondary outcomes

Study Arms (2)

Waterpipe with Health Warning Label (HWL)

EXPERIMENTAL

All participants will complete a lab visit where they will smoke waterpipe with HWL for up to 45 minutes.

Behavioral: Test Health Warning Label (HWL)

Absence of Waterpipe without Health Warning Label (HWL)

EXPERIMENTAL

All participants will complete a lab visit where they will smoke waterpipe without HWL for up to 45 minutes.

Behavioral: Test without Health Warning Label (no-HWL)

Interventions

Effect of Health Warning Label (HWL)

Waterpipe with Health Warning Label (HWL)

Effect of no Health Warning Label (no-HWL)

Absence of Waterpipe without Health Warning Label (HWL)

Eligibility Criteria

Age21 Years - 35 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Age of 21-35 years.
  • Beginners WP smokers (defined as started WP smoking in the past 6 months, but smoke WP less than weekly); or established WP smokers (defined as smoked at least once a week in the past 6 months).
  • Generally healthy individuals (determined by physical examination).
  • Is willing to provide informed consent.
  • Is willing to attend the lab as required by the study protocol.
  • Have abstained from WP for 12 hours prior to each lab session.

You may not qualify if:

  • Women who are breast-feeding or test positive for pregnancy (by urinalysis at screening).
  • Individuals with self-reported history of chronic disease or psychiatric conditions.
  • Individuals with history of or active cardiovascular disease, low or high blood pressure, seizures, and regular use of prescription medications (other than vitamins or birth control).
  • Report tobacco product use regularly (\> 5 times/month in the past year).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Florida International University

Miami, Florida, 33199, United States

Location

MeSH Terms

Conditions

Water Pipe SmokingSmoking CessationHealth Risk Behaviors

Condition Hierarchy (Ancestors)

Pipe SmokingSmokingBehaviorHealth Behavior

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
CROSSOVER
Model Details: The investigators will conduct a 2x2x2x4 within-subject (2: HWL vs no-HWL x 2: pre- vs post- smoking) and between-subject (2: beginner vs established smokers x 4: HWLs) experimental study. Participant in each group (beginner, established smoker) will be randomly assigned to one of the 4 HWLs conditions, and undergo 2 WP smoking sessions that differ by HWL on the WP device (HWL vs. no-HWL), with pre-/post-smoking assessment of harm perception, intention to quit, puffing behavior, satisfaction, urge to smoke, and toxicant exposure. The investigators will use Latin Square crossover design balanced for carry-over effect (random order of 4 HWL condition), and to ensure equal distribution of study participants across gender.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 28, 2022

First Posted

April 8, 2022

Study Start

October 3, 2022

Primary Completion

December 9, 2024

Study Completion

December 9, 2024

Last Updated

December 10, 2024

Record last verified: 2024-12

Data Sharing

IPD Sharing
Will not share

Locations